advanced colorectal cancer

Showing 1 - 25 of 48

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Advanced Colorectal Cancer Trial in Hangzhou (Cetuximab Dabrafenib Tislelizumab)

Not yet recruiting
  • Advanced Colorectal Cancer
  • Cetuximab Dabrafenib Tislelizumab
  • Hangzhou, Zhejing, China
    Zhejiang Cancer Institute & Hospital
Jul 19, 2023

Advanced Colorectal Cancer Trial in Hangzhou (Fruquintinib Combined With Chemotherapy)

Not yet recruiting
  • Advanced Colorectal Cancer
  • Fruquintinib Combined With Chemotherapy
  • Hangzhou, Zhejing, China
    Zhejiang Cancer Institute & Hospital
Jun 29, 2023

Advanced Colorectal Cancer Trial in Guangzhou

Recruiting
  • Advanced Colorectal Cancer
    • Guangzhou, Guangdong, China
      Sun Yat-sen University Cancer Center
    Feb 7, 2023

    New Patient Stratification Tools in MSS RAS mt mCRC

    Completed
    • Advanced Colorectal Cancer
      • Heidelberg, Germany
      • +9 more
      Nov 25, 2022

      Advanced Colorectal Cancer, Circulating Tumor DNA Trial in Shanghai (Local treatment)

      Recruiting
      • Advanced Colorectal Cancer
      • Circulating Tumor DNA
      • Local treatment
      • Shanghai, China
        Fudan University Shanghai Cancer Center
      Aug 8, 2022

      Advanced Colorectal Cancer, Metastatic Colorectal Cancer Trial in Worldwide (MRTX849, Cetuximab, mFOLFOX6 Regimen)

      Recruiting
      • Advanced Colorectal Cancer
      • Metastatic Colorectal Cancer
      • Birmingham, Alabama
      • +208 more
      Aug 3, 2022

      Advanced Breast Cancer, Advanced Colorectal Cancer, Cancer Rehabilitation Trial (In-person rehabilitaiton group, Virtual

      Not yet recruiting
      • Advanced Breast Cancer
      • +2 more
      • In-person rehabilitaiton group
      • Virtual rehabilitation group
      • (no location specified)
      Jun 15, 2022

      Advanced Colorectal Cancer Trial in Worldwide (DS-8201a 5.4 mg/kg Q3W, DS-8201a 6.4 mg/kg Q3W)

      Active, not recruiting
      • Advanced Colorectal Cancer
      • DS-8201a 5.4 mg/kg Q3W
      • DS-8201a 6.4 mg/kg Q3W
      • Louisville, Kentucky
      • +44 more
      Jun 10, 2022

      Advanced Colorectal Cancer Trial (Bevacizumab combined with Oxaliplatin and TAS-102)

      Not yet recruiting
      • Advanced Colorectal Cancer
      • Bevacizumab combined with Oxaliplatin and TAS-102
      • (no location specified)
      May 16, 2022

      Advanced Colorectal Cancer, Small Intestinal Cancer, Appendiceal Cancer Trial in China (JAB-21822, Cetuximab)

      Recruiting
      • Advanced Colorectal Cancer
      • +2 more
      • Beijing, Beijing, China
      • +11 more
      Mar 22, 2022

      Advanced Colorectal Cancer: A Real-world Study

      Active, not recruiting
      • Advanced Colorectal Cancer
        • Beijing, Beijing, China
        • +1 more
        Mar 9, 2022

        Advanced Hepatocellular Carcinoma, Advanced Colorectal Cancer, Advanced Gastric Cancer Trial in Hangzhou (EPCAM CAR-T)

        Recruiting
        • Advanced Hepatocellular Carcinoma
        • +3 more
        • EPCAM CAR-T
        • Hangzhou, China
          First affiliated hospital, School of Medicine, Zhejiang Universi
        Jan 12, 2022

        Advanced Colorectal Cancer Trial in Fuzhou (Surufatinib)

        Recruiting
        • Advanced Colorectal Cancer
        • Fuzhou, Fujian, China
          China, Fujian
        Oct 27, 2021

        First-line Treatment, Advanced Colorectal Cancer Trial in Tianjin (Trifluridine/Tipiracil)

        Recruiting
        • First-line Treatment
        • Advanced Colorectal Cancer
        • Tianjin, China
          Tianjin Medical University Cancer Institute and Hospital
        Oct 15, 2021

        Advanced Colorectal Cancer Trial (LEAC-102 500mg capsule and FOLFOX + Bevacizumab/Cetuximab)

        Not yet recruiting
        • Advanced Colorectal Cancer
        • LEAC-102 500mg capsule and FOLFOX + Bevacizumab/Cetuximab
        • (no location specified)
        Sep 28, 2021

        Advanced Colorectal Cancer Trial in Guangzhou (Anlotinib Hydrochloride)

        Recruiting
        • Advanced Colorectal Cancer
        • Anlotinib Hydrochloride
        • Guangzhou, Guangdong, China
          Guangdong Provincial Hospital of Chinese Medicine
        Sep 3, 2021

        Advanced Colorectal Cancer Trial in Nanjing (Bevacizumab?Oxaliplatin?Irinotecan?Capecitabine)

        Recruiting
        • Advanced Colorectal Cancer
        • Nanjing, Jiangsu, China
          Jiangsu Cancer Institute & Hospital
        Aug 27, 2021

        Advanced Colorectal Cancer Trial in China (Raltitrexed, Irinotecan, Oxaliplatin)

        Recruiting
        • Advanced Colorectal Cancer
        • Nanjing, Jiangsu, China
        • +3 more
        Aug 27, 2021

        Advanced Colorectal Cancer Trial in New York (MEDI4736)

        Completed
        • Advanced Colorectal Cancer
        • New York, New York
          Memorial Sloan Kettering Cancer Center
        May 25, 2021

        Advanced Colorectal Cancer Trial in China (Surufatinib,Camrelizumab,Irinotecan,GM-CSF)

        Recruiting
        • Advanced Colorectal Cancer
        • Changzhou, Jiangsu, China
        • +4 more
        Jun 11, 2021

        Advanced Colorectal Cancer Trial in Cyprus, Greece (Panitumumab)

        Terminated
        • Advanced Colorectal Cancer
        • Strovolos, Nicosia, Cyprus
        • +7 more
        Jun 2, 2021

        Advanced Colorectal Cancer Trial in Canada, Spain, United States (PM060184)

        Completed
        • Advanced Colorectal Cancer
        • Los Angeles, California
        • +4 more
        Apr 30, 2021

        Advanced Glioblastoma, Advanced Colorectal Cancer, Advanced Triple-negative Breast Cancer Trial in Boston (ONC201)

        Withdrawn
        • Advanced Glioblastoma
        • +3 more
        • Boston, Massachusetts
          Massachusetts General Hospital
        Apr 28, 2021

        Advanced Colorectal Cancer Trial in Benevento, Napoli, Potenza (regorafenib)

        Active, not recruiting
        • Advanced Colorectal Cancer
        • Benevento, Italy
        • +3 more
        Mar 3, 2021

        Symptomatic Colorectal Cancer, Advanced Colorectal Cancer, Colorectal Cancer With Cachexia Trial in Warsaw (Xilonix, Placebo)

        Completed
        • Symptomatic Colorectal Cancer
        • +2 more
        • Xilonix
        • Placebo
        • Warsaw, Poland
          XBiotech Investigative Site
        Feb 25, 2021